Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library [version 1; referees: 2 approved]

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library [version 1; referees: 2 approved]

Background The recent epidemics of Zika virus (ZIKV) implicated it as the cause of serious and potentially lethal congenital conditions such microcephaly and other central nervous system defects, as well as the development of the Guillain-Barré syndrome in otherwise healthy patients. Recent findings...

Full description

Bibliographic Details
Main Authors: Bruno S. Pascoalino, Gilles Courtemanche, Marli T. Cordeiro, Laura H. V. G. Gil, Lucio Freitas-Junior
Format: Article
Language:English
Published: F1000 Research Ltd 2016-10-01
Series:F1000Research
Subjects:
Drug Discovery & Design
Viral Infections (without HIV)
Virology
Online Access:https://f1000research.com/articles/5-2523/v1

Internet

https://f1000research.com/articles/5-2523/v1

Similar Items